186 related articles for article (PubMed ID: 22406608)
1. VIP and calcitonin-producing pancreatic neuroendocrine tumor with watery diarrhea: clinicopathological features and the effect of somatostatin analogue.
Kon T; Wada R; Suzuki R; Nakayama Y; Ebina Y; Yagihashi S
JOP; 2012 Mar; 13(2):226-30. PubMed ID: 22406608
[TBL] [Abstract][Full Text] [Related]
2. A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome.
Ichimura T; Kondo S; Okushiba S; Morikawa T; Katoh H
Int J Gastrointest Cancer; 2003; 33(2-3):99-102. PubMed ID: 14716055
[TBL] [Abstract][Full Text] [Related]
3. Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels.
Nasir A; Gardner NM; Strosberg J; Ahmad N; Choi J; Malafa MP; Coppola D; Kwekkeboom DJ; Teunissen JJ; Kvols LK
Pancreas; 2008 Apr; 36(3):309-13. PubMed ID: 18362846
[TBL] [Abstract][Full Text] [Related]
4. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome.
Larsson LI; Schwartz T; Lundqvist G; Chance RE; Sundler F; Rehfeld JF; Grimelius L; Fahrenkrug J; Schaffalitzky de Muckadell O; Moon N
Am J Pathol; 1976 Dec; 85(3):675-84. PubMed ID: 998736
[TBL] [Abstract][Full Text] [Related]
6. A case of the watery diarrhea-hypokalemia-achlorhydria syndrome: successful preoperative treatment of watery diarrhea with a somatostatin analogue.
Yoshioka M; Sakazume M; Fukagawa M; Seki T; Honma K; Uchida K; Yoshida K; Miyake Y; Yamaguchi K
Jpn J Clin Oncol; 1989 Sep; 19(3):294-8. PubMed ID: 2554028
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid arthritis associated with the use of Sandostatin® LAR® depot in a patient with pancreatic neuroendocrine tumor. An association or a coincidence? The first case report.
Saif MW
JOP; 2011 Jul; 12(4):425-8. PubMed ID: 21737909
[TBL] [Abstract][Full Text] [Related]
8. Hypokalemic rhabdomyolysis without watery diarrhea: an unexpected presentation of a pancreatic neuro-endocrine tumor.
Rossi V; Saibeni S; Sinigaglia L; Peracchi M; Parafioriti A; Vecchi M
Am J Gastroenterol; 2006 Mar; 101(3):669-72. PubMed ID: 16464230
[TBL] [Abstract][Full Text] [Related]
9. Clinical and hormonal aspects of the watery diarrhea-hypokalemia-achlorhydria (WDHA) syndrome due to vasoactive intestinal polypeptide (VIP)-producing tumor.
Yamaguchi K; Abe K; Adachi I; Tanaka M; Ueda M; Oka Y; Miyakawa S; Kameya T; Yanaihara N
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():79-86. PubMed ID: 7014208
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome.
Brunt LM; Mazoujian G; O'Dorisio TM; Wells SA
Surgery; 1994 Mar; 115(3):362-9. PubMed ID: 8128360
[TBL] [Abstract][Full Text] [Related]
11. [Metastasizing pancreatic vipoma. Its diagnosis and therapy with the somatostatin analog octreotide].
Scheffold N; Arnold R; Cyran J
Dtsch Med Wochenschr; 1995 Oct; 120(43):1463-7. PubMed ID: 7588006
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin-producing pancreatic somatostatinoma: report of a case.
Sugimoto F; Sekiya T; Saito M; Iiai T; Suda K; Nozawa A; Nakazawa T; Ishizaki T; Ikarashi T
Surg Today; 1998; 28(12):1279-82. PubMed ID: 9872549
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
[TBL] [Abstract][Full Text] [Related]
15. Large cell carcinoma with calcitonin and vasoactive intestinal polypeptide-associated Verner-Morrison syndrome.
Pratz KW; Ma C; Aubry MC; Vrtiska TJ; Erlichman C
Mayo Clin Proc; 2005 Jan; 80(1):116-20. PubMed ID: 15667039
[TBL] [Abstract][Full Text] [Related]
16. Medullary carcinoma of the thyroid, pancreatic nesidioblastosis and microadenosis, and pancreatic polypeptide hypersecretion: a new association and clinical and hormonal responses to long-acting somatostatin analog SMS 201-995.
Jerkins TW; Sacks HS; O'Dorisio TM; Tuttle S; Solomon SS
J Clin Endocrinol Metab; 1987 Jun; 64(6):1313-9. PubMed ID: 2883196
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitonin.
Eskens FA; Roelofs EJ; Hermus AR; Verhagen CA
Anticancer Res; 1997; 17(6D):4667-70. PubMed ID: 9494586
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract.
Hejna M; Hamilton G; Brodowicz T; Haberl I; Fiebiger WC; Scheithauer W; Virgolini I; Köstler WJ; Oberhuber G; Raderer M
Anticancer Res; 2001; 21(2A):1183-7. PubMed ID: 11396161
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
[TBL] [Abstract][Full Text] [Related]
20. Watery diarrhea, hypokalemia, achlorhydria syndrome in an infant: effect of the long-acting somatostatin analogue SMS 201-995 on the disease and linear growth.
Smith SS; Shulman DI; O'Dorisio TM; McClenathan DT; Borger JA; Bercu BB; Root AW
J Pediatr Gastroenterol Nutr; 1987; 6(5):710-6. PubMed ID: 2891808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
